Status:

COMPLETED

Strategies for Teaching Verbs

Lead Sponsor:

Vanderbilt University Medical Center

Conditions:

Language Development Disorders

Down Syndrome

Eligibility:

All Genders

3-17 years

Phase:

NA

Brief Summary

This study is designed to evaluate whether children with Down syndrome and children with typical development exhibit different levels of accuracy demonstrating novel verbs taught under three condition...

Eligibility Criteria

Inclusion

  • Must use oral communication as their primary means of communication
  • Must be monolingual English speakers
  • Behaviorally able to attend for 20 minutes
  • Children with typical development must demonstrate no more than one standard deviation below the mean on the speech and language measures

Exclusion

  • Nonverbal cognitive score less than three standard deviations below the mean (standard score of 54 below)
  • Identified hearing loss or failed hearing screening
  • Uncorrected vision impairment
  • Motor impairment that prevents completion of study activities
  • Concomitant disorders (e.g., Autism spectrum disorder)

Key Trial Info

Start Date :

March 21 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 2 2021

Estimated Enrollment :

44 Patients enrolled

Trial Details

Trial ID

NCT03441685

Start Date

March 21 2018

End Date

July 2 2021

Last Update

June 7 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Vanderbilt Bill Wilkerson Center

Nashville, Tennessee, United States, 37232